Exact Mass: 412.1014

Exact Mass Matches: 412.1014

Found 52 metabolites which its exact mass value is equals to given mass value 412.1014, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Patientoside A

1-(4-chloro-1-hydroxy-3-methyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethan-1-one

C19H21ClO8 (412.0925)

Patientoside A is found in herbs and spices. Patientoside A is a constituent of the roots of Rumex patientia (patience dock). Constituent of the roots of Rumex patientia (patience dock). Patientoside A is found in herbs and spices.

Zileuton O-glucuronide

(2S,3S,4S,5R,6S)-6-({[1-(1-benzothiophen-2-yl)ethyl](C-hydroxycarbonimidoyl)amino}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H20N2O8S (412.094)

Zileuton O-glucuronide is a metabolite of zileuton. Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation of zileuton, known as ZYFLO, is taken four times per day. (Wikipedia)

Cys Cys Ser Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C13H24N4O7S2 (412.1086)

Cys Cys Thr Ser

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C13H24N4O7S2 (412.1086)

Cys Ser Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C13H24N4O7S2 (412.1086)

Cys Ser Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C13H24N4O7S2 (412.1086)

Cys Thr Cys Ser

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C13H24N4O7S2 (412.1086)

Cys Thr Ser Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C13H24N4O7S2 (412.1086)

Ser Cys Cys Thr

(2S,3R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C13H24N4O7S2 (412.1086)

Ser Cys Thr Cys

(2R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C13H24N4O7S2 (412.1086)

Ser Thr Cys Cys

(2R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H24N4O7S2 (412.1086)

Thr Cys Cys Ser

(2S)-2-[(2R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C13H24N4O7S2 (412.1086)

Thr Cys Ser Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C13H24N4O7S2 (412.1086)

Thr Ser Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C13H24N4O7S2 (412.1086)

Patientoside A

1-(4-chloro-1-hydroxy-3-methyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethan-1-one

C19H21ClO8 (412.0925)

(1-METHYL-1H-PYRROL-2-YL)METHYLAMINE

C23H26BrP (412.0955)

1-Chloro-9,10-bis(phenylethynyl)anthracene

C30H17Cl (412.1019)

1,5-Pentanediol,1,5-bis(4-methylbenzenesulfonate)

C19H24O6S2 (412.1014)

isoamyltriphenylphosphonium bromide

C23H26BrP (412.0955)

9,10-bis-(Phenylethynyl)-2-chloroanthracene

C30H17Cl (412.1019)

1,3-bis(tosyloxy)-2,2-dimethylpropane

C19H24O6S2 (412.1014)

MES hemisodium salt

C12H25N2NaO8S2 (412.095)

Pentyltriphenylphosphonium bromide

C23H26BrP (412.0955)

4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-hydroxy-6-quinolinecarboxamide

C20H17ClN4O4 (412.0938)

Ethyl 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylate acetate (1:1)

C17H20N2O8S (412.094)

methyl 3-(4-methylsulfonylphenoxy)-5-phenylmethoxybenzoate

C22H20O6S (412.0981)

Chitobiose

chitobiose dihydrochloride

C12H26Cl2N2O9 (412.1015)

Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated. [HMDB]

4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione

C22H21ClN2O2S (412.1012)

(2s,3s,6r,8r)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione

C22H21ClN2O2S (412.1012)

(2r,3s,4s)-4-(benzylsulfanyl)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C22H20O6S (412.0981)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[(2-oxo-5h-furan-3-yl)methoxy]oxan-2-yl]methyl 3,4-dihydroxybenzoate

C18H20O11 (412.1006)

1-(4-chloro-1-hydroxy-3-methyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethanone

C19H21ClO8 (412.0925)

(2s,3s,6s,8r)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione

C22H21ClN2O2S (412.1012)